The UK Vaccine Minister Nadhim Zahawi has said he received a recommendations from the Joint Committee on Vaccination and Immunisation (JCVI) about whether to recommend vaccines for under-18s, BBC News reported on Monday.
Zahawi told BBC Breakfast he will make a statement to Parliament later, but he says the JCVI has recommended that children with medical conditions that make them vulnerable to COVID-19 should be vaccinated, along with those who live with clinically vulnerable people.
He also said the committee recommends that children close to their 18th birthday should have the vaccine.
However, the JCVI will be keeping under review whether or not to vaccinate healthy children aged 12 to 17.
Reportedly, the committee is concerned about some data suggesting there may be rare cases of myocarditis, an inflammation of the heart muscle, linked to the vaccine.
LEO Pharma advances delgocitinib cream into phase 3 trial for lichen sclerosus
HistoIndex partners Houston Research Institute
Formosa Pharmaceuticals licenses APP13007 ophthalmic therapy to Samil for South Korea
Bambusa Therapeutics reports first patient dosed in proof-of-concept COPD trial
Elanco Animal Health's Befrena (tirnovetmab) receives USDA approval for canine dermatitis
Sanofi and Regeneron's Dupixent gains Japan approval for paediatric asthma patients aged 6 to 11
Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA
Alvotech launches first-in-market golimumab biosimilar in Europe
Physiomics secures follow-on UK contract for Phase 2 study support
RedHill Biopharma reports positive opaganib data in venetoclax-resistant CLL
InduPro secures strategic investment and collaboration with Sanofi to advance autoimmune therapy
Innovent Biologics reports first participant dosed in Phase 1 trial of IBI3011